Michael Levy

45PUBLICATIONS

218CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseasesOptical technologyVision scienceInnate immunity

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (45)

Sort by Publication Date:

|Jul 15, 2026

CD4<sup>+</sup> T cells reactive to Epstein-Barr virus late lytic antigens are enriched in individuals with multiple sclerosis.

|Jul 13, 2026

Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.

|Apr 16, 2026

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

|Apr 06, 2026

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.

Philippe A Bilodeau, Mattia Wruble Clark, Avanteeka Ganguly

|Mar 05, 2026

Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.

J L Bennett, S Bhattacharyya, A Zabeti

|Feb 11, 2026

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series.

Paulus S Rommer, Wei Jiang, Jan P Nolte

Pageof 8

Frequent Collaborators

9 joint publications

Philippe Antoine Bilodeau

Elias S Sotirchos

João Vitor Mahler

Friedemann Paul

Shamik Bhattacharyya

Takahisa Mikami

Itay Lotan

I Izbudak

Hesham Abboud

Giovanna Sophia Manzano

Frequent Collaborators

9 joint publications

Philippe Antoine Bilodeau

6 joint publications

Elias S Sotirchos

6 joint publications

João Vitor Mahler

6 joint publications

Friedemann Paul